Cytiva以16亿美元战略投资完成亚洲、美国和欧洲项目 - BioSpectrum Asia
Cytiva completes projects in Asia, US & Europe with $1.6 B strategic investment - BioSpectrum Asia
#Cytiva completes#BioSpectrum Asia#completes projects#Asia Cytiva#strategic investment
生命科学资讯
生物技术与制药领域的最新动态
Cytiva公布至2028年16亿美元设施投资计划 - 国际生物工艺
Cytiva outlines $1.6bn facility investment plans through 2028 - BioProcess International
#BioProcess International#Cytiva outlines#facility investment#investment plans#International Cytiva
Cytiva完成16亿美元战略投资，进一步强化全球供应链布局 - 基因工程与生物技术新闻
Cytiva Completes $1.6 billion in Strategic Investments to Further Enhance Global Supply Chain - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Strategic Investments#Enhance Global#Global Supply#Cytiva Completes
加速您的基因治疗之旅——量身定制的服务尽在《国际生物工艺》
Accelerate Your Gene Therapy Journey with Services Tailored to You - BioProcess International
#Gene Therapy#Therapy Journey#Services Tailored#BioProcess International#International Accelerate
伦敦大学学院UCL Cytiva卓越中心
UCL Cytiva Centre of Excellence (COE) - University College London
#University College#Cytiva Centre#UCL Cytiva#College London#London UCL
Cytiva与EurekaBio达成战略合作，共同推进中国细胞与基因治疗中慢病毒载体生产——Endpoints新闻
Cytiva and EurekaBio form strategic partnership to advance lentiviral vector manufacturing for cell and gene therapy in China - Endpoints News
#China Endpoints#EurekaBio form#form strategic#strategic partnership#advance lentiviral
Nuclera与Cytiva携手合作，加速药物研发中蛋白质表征进程 - 科学家网
Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development - the-scientist.com
#Cytiva collaborate#drug development#accelerate characterization#Nuclera#Cytiva
Cytiva子公司请求撤销在安进美国地舒单抗诉讼中对Accord及Intas发出的传票——Pearce IP
Cytiva Subsidiary Seeks to Quash Subpoena Issued in Amgen’s US Denosumab Litigation Against Accord & Intas - Pearce IP
#Subsidiary Seeks#Quash Subpoena#Subpoena Issued#Denosumab Litigation#Cytiva Subsidiary
Nuclera与丹纳赫旗下美国盟友强化蛋白质业务布局——商业周刊
Nuclera and Danaher-owned US ally boost protein proposition - Business Weekly
#Business Weekly#ally boost#boost protein#Weekly Nuclera#protein proposition
提高CGT生产效率以加速交付降低成本——GEN《基因工程与生物技术新闻》
Improving CGT Production to Speed Delivery and Lower Cost - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#CGT Production#Speed Delivery#Lower Cost#Improving CGT
生产者细胞系：大规模基因疗法的关键制造者 - 《基因工程与生物技术新闻》
Producer Cell Lines: Large-Scale Gene Therapy Hitmakers - GEN - Genetic Engineering and Biotechnology News
#Cell Lines#Genetic Engineering#Gene Therapy#Large-Scale Gene#Therapy Hitmakers
Xcellerex 500升与2000升生物反应器 - GEN - 基因工程与生物技术新闻
Xcellerex 500 L and 2,000 L Bioreactors - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Bioreactors GEN#Genetic#GEN#Engineering
Cytiva与Asimov携手推进新一代细胞系设计与工艺开发 - 基因工程与生物技术新闻
Cytiva and Asimov Collaborate on NextGen Cell Line Design and Process Development - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Asimov Collaborate#Cell Line#Line Design#Process Development
Cytiva推出两款新型Protein A树脂，提升单抗捕获成本效益——印度《生物光谱》
Cytiva develops two new protein A resins bringing cost efficiency to mAb capture - BioSpectrum India
#Cytiva develops#BioSpectrum India#resins bringing#bringing cost#cost efficiency
Cytiva扩充产品线，推出新型MabSelect树脂，采用可再生琼脂糖，助力单克隆抗体规模化、经济高效生产——Express Pharma报道
Cytiva expands portfolio with new MabSelect Resins made from renewable agarose for scalable, cost-efficient mAb manufacturing - Express Pharma
#Express Pharma#MabSelect Resins#Resins made#cost-efficient mAb#Cytiva expands
解锁PROTACs在药物发现领域的潜力 - 科技网络
Unlocking the Potential of PROTACs in Drug Discovery - Technology Networks
#Drug Discovery#Technology Networks#Discovery Technology#Networks Unlocking#Potential
Cytiva扩展MabSelect树脂产品线，推出经济高效且可扩展的单抗纯化新方案——BioSpectrum Asia报道
Cytiva expands MabSelect resin portfolio with new solutions for cost-effective and scalable mAb purification - BioSpectrum Asia
#Cytiva expands#BioSpectrum Asia#expands MabSelect#MabSelect resin#resin portfolio
Cytiva扩展Xcellerex X平台，新增500升至2000升生物反应器——SelectScience报道
Cytiva broadens Xcellerex X-platform to include 500 L and 2000 L bioreactors - SelectScience
#Xcellerex X-platform#broadens Xcellerex#Cytiva broadens#SelectScience Cytiva#bioreactors SelectScience
Cytiva扩充生物反应器产品线，新增500升与2000升型号，将于2025年INTERPHEX展会亮相——BioPharm International报道
Cytiva Expands Bioreactor Portfolio with Addition of 500-L and 2000-L Bioreactors, Which Will be Exhibited at INTERPHEX 2025 - BioPharm International
#Expands Bioreactor#Bioreactor Portfolio#Cytiva Expands#BioPharm International#International Cytiva
2025年塑造医疗与生物科学行业的趋势 - 亚洲生物科技视野
Trends shaping the Healthcare and Bioscience industries in 2025 - BioSpectrum Asia
#BioSpectrum Asia#Bioscience industries#Trends shaping#Asia Trends#Healthcare